Craig Philips takes the helm at CTI
This article was originally published in Scrip
Cell Therapeutics(US) has announced that Craig Philips has assumed his role as president, and will concentrate on managing the company's drug development and commercial operations. Mr Philips was most recently vice-president and general manager of Bayer Healthcare Oncology. He will report to James Bianco, who has served as Cell Therapeutics' president and chief executive officer since its founding and will remain with the company as CEO.